Anja B Krammer
CIK 1418077 · President · last filed 2024-06-28
Anja B Krammer is a President who has filed 12 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for VVOS, was dated Jun 28, 2024. Across all open-market trades the lifetime net is −$107.7K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BPMX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1505 ADAMS DRIVE, SUITE D
MENLO PARK, CA 94025
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VVOS | Director | — | $0.15 | — | $0 | 3 | 2024-06-28 |
| Timber Pharmaceuticals, Inc. (BPMX) Delisted | President | 157,010 | — | — | -$107.7K | 9 | 2019-01-25 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-28 | VVOS | Grant (A) | — | $0 | EDGAR |
| 2022-12-28 | VVOS | Grant (A) | — | $0 | EDGAR |
| 2021-08-10 | VVOS | Grant (A) | — | $0 | EDGAR |
| 2019-01-25 | Timber Pharmaceuticals, Inc. (BPMX) Delisted | Sell (S) | −115,874 | -$12.7K | EDGAR |
| 2018-10-12 | Timber Pharmaceuticals, Inc. (BPMX) Delisted | Sell (S) | −500,000 | -$95.0K | EDGAR |
| 2018-09-11 | Timber Pharmaceuticals, Inc. (BPMX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-09 | Timber Pharmaceuticals, Inc. (BPMX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-22 | Timber Pharmaceuticals, Inc. (BPMX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-19 | Timber Pharmaceuticals, Inc. (BPMX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-12 | Timber Pharmaceuticals, Inc. (BPMX) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.